American College of Clinical Pharmacy
      Search      Cart
         

2023 ACCP/ASHP BCACP Clinical Sessions

ACCP   ASHP

Series Overview

The 2023 ACCP/ASHP BCACP Clinical Sessions are part of the professional development programs for recertification of the Board Certified Ambulatory Care Pharmacist and/or the Board Certified Geriatric Pharmacist approved by the Board of Pharmacy Specialties (BPS) and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants' skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release date: February 7, 2024
Specialty Recertification credit expiration date: December 17, 2024
ACPE credit expiration date: December 17, 2026

Program Content

The 2023 ACCP/ASHP BCACP Clinical Sessions are offered in four presentations. Each presentation focuses on a different Ambulatory Care Pharmacy/Geriatric Pharmacy topic that is highly relevant for day-to-day practice. Topics include patient access to reproductive healthcare, updates in the management of chronic kidney disease, hypercholesterolemia treatment recommendations, and treating obesity in older adults.

BCACP Clinical Session
Changing the Way Patients Access Reproductive Healthcare

There are many barriers to access to Women's Health and contraception. This session will help to decrease those barriers by providing resources to help pharmacists advocate for the expansion of laws in their state to include pharmacist contraceptive services as well as to assist pharmacists in rolling out pharmacist contraceptive services if their state already has laws in place. For states with laws in place, the uptick has been low at times. By provided case-based examples and tools readily at their disposal, pharmacists will feel more empowered to establish or expand services to include Women's Health.

BCACP/BCGP Clinical Session
Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease

This session will provide attendees with practical information on how to individualize drug therapies for patients living with chronic kidney disease. The landscape of diagnosis and management of CKD is continually evolving, with evidence-based recommendations changing dramatically in the past few years. This session will provide an overview of these crucial and timely updates with an opportunity for attendees to apply the evidence to simulated patient cases while focusing on overcoming therapeutic inertia and advocating for equitable care.

BCACP/BCGP Clinical Session
The Cholesterol Limbo: How Low Should You Go?

This session will focus on the hypercholesterolemia treatment recommendations and recent literature supporting the role of statin and nonstatin therapy. Faculty will review clinical trial data, especially with newer agents, as well as discuss the role of pharmacists in hypercholesterolemia management. Many clinicians follow the 2018 ACC-AHA cholesterol guideline recommendations as the “gold standard” evidence-based guideline by implementing a fixed-dose, intensity-based statin treatment. This may be appropriate for many patients. However, several high-risk patients may require more intense therapy and targeting further reductions in LDL-C with nonstatin therapy including ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran, and icosapent ethyl. This presentation highlights how low cholesterol can go safely to reduce cardiovascular risk, especially in older adults. Interactive case studies will be used to facilitate learning.

BCACP/BCGP Clinical Session
Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults

Although behavioral interventions are the foundation of weight management in adults, the effectiveness of these strategies may be limited. In older adults, there are limited data demonstrating that lifestyle interventions are best for both safety and efficacy. There are significant concerns that aggressive lifestyle measures for weight loss, especially through calorie restriction without resistance exercises in older adults may result in increased sarcopenia, frailty, functional decline, fractures, and malnutrition. The addition of pharmacologic therapies for long-term management of obesity may help adult patients achieve optimal outcomes. As the medications available for weight management increase, health professionals are faced with options for individualizing treatment regimens. The purpose of this session will be to review management strategies for weight loss, evaluate the latest literature on pharmacotherapy, and apply the guidance to clinical pharmacy practice in adult and older adult populations. Presenters will also discuss special considerations including pharmacokinetic and pharmacodynamic changes, polypharmacy, cognitive and functional status, caregiver involvement and care venues, food insecurity, and socioeconomic challenges for weight management in the older adult. Attendees will participate in case-based learning scenarios via the audience response system and an interactive activity that will increase familiarity with the risks and benefits of anti-obesity medications.

Faculty

Changing the Way Patients Access Reproductive Healthcare

Cynthia A. King, Pharm.D., BCACP Cynthia A. King, Pharm.D., BCACP
Ambulatory Care Pharmacy Specialist
MetroHealth System
Seven Hills, Ohio
Lorinda Anderson, Pharm.D., BCPS Lorinda Anderson, Pharm.D., BCPS
Clinical Associate Professor
Oregon State University
College of Pharmacy
Albany, Oregon
Jordan Cloonan, Pharm.D. Jordan Cloonan, Pharm.D.
PGY-2 Ambulatory Care Pharmacy Resident
MetroHealth Medical Center
Kirtland, Ohio

Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease

Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE
Assistant Dean for Basic Science and Pre-clerkship Education
Vice-Chair of Foundational Sciences & Humanities
Associate Professor of Chemical and Molecular Pharmacology
Rosalind Franklin University of Medicine and Science
Chicago, Illinois

The Cholesterol Limbo: How Low Should You Go?

Joel C. Marrs, Pharm.D., MPH, FCCP, BCACP, BCCP, BCPS, CLS Joel C. Marrs, Pharm.D., MPH, FCCP, BCACP, BCCP, BCPS, CLS
Professor and Coordinator of Clinical Outreach
University of Tennessee Health Science Center
College of Pharmacy
Nashville, Tennessee
Matthew Kostoff, Pharm.D., BCACP, BCPS Matthew Kostoff, Pharm.D., BCACP, BCPS
Clinical Pharmacy Specialist
University Hospitals
Hudson, Ohio

Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults

Lourdes Cross, Pharm.D., BCACP, CDE Lourdes Cross, Pharm.D., BCACP, CDE
Associate Professor
Sullivan University
College of Pharmacy and Health Sciences
Louisville, Kentucky
Dana G. Carroll, Pharm.D., BCGP, BCPS Dana G. Carroll, Pharm.D., BCGP, BCPS
Clinical Professor
Auburn University
Harrison College of Pharmacy
Northport, Alabama

Reviewers

  • Jill S. Borchert, Pharm.D., FCCP, BCPS, BCACP
  • Sue Dombrowski, MS, RPh
  • Michelle Hilaire, Pharm.D., FCCP, CDE, BCPS, BCACP
  • Olga Hilas, Pharm.D., MPH, BCPS, BCGP
  • Lauren Lakdawala, Pharm.D., BCACP
  • Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
  • Kyle Sheffer, Pharm.D., BCACP

Financial Relationship Disclosures

Target Audience and Learning Objectives

Target Audience
These recertification activities are intended for the Board Certified Ambulatory Care Pharmacist (BCACP) and the Board Certified Geriatric Pharmacist (BCGP) and those interested in patient access to reproductive healthcare, updates in the management of chronic kidney disease, hypercholesterolemia treatment recommendations, and treating obesity in older adults.

Learning Objectives
Learning Objectives PDF

Continuing Pharmacy Education Credit

ACPEThe American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

CommendationsThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Approved_ProviderThe American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCACP.

BCACP Clinical Session
Changing the Way Patients Access Reproductive Healthcare

Universal Activity Number: 0217-9999-23-077-H01-P
Contact Hours: 2.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease

Universal Activity Number: 0217-9999-23-078-H01-P
Contact Hours: 1.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
The Cholesterol Limbo: How Low Should You Go?

Universal Activity Number: 0204-9999-23-290-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults

Universal Activity Number: 0204-9999-23-327-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

Methods and CE Requirements

Continuing Pharmacy Education Credit

To be eligible to earn continuing pharmacy education credit, learners must purchase the product, review all content, successfully complete, submit and pass the web-based posttest associated with each module within the course by December 17, 2026. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

Recertification Credit

BCACP Credit   BCGP Credit

To be eligible to earn BCACP and BCGP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the web-based posttest associated with each module by December 17, 2024. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.

The passing point to earn BCACP and BCGP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the Specialty Recertification Credit posttest deadline that meets this passing point will earn BCACP and BCGP recertification credits. These credits will be assigned as of the date of test submission.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

For statements of recertification credit, visit www.bpsweb.org. Questions regarding the number of hours required for BCACP or BCGP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.

Technical Requirements

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

Fees

Specialty Recertification
Offers up to 6.0 continuing pharmacy education credits/recertification credits
 

Includes:

  • streaming audio/slide synchronized presentations
  • downloadable mp3 audio files
  • downloadable mp4 video files
  • downloadable/printable PDFs of presentation slides
  • online posttest(s) for CPE/Recertification credit
  • Recertification Credit Deadline: December 17, 2024
Price: $260.00 Member: $155.00